Craig-Hallum Reiterates a Buy Rating on Cellebrite DI Ltd. (CLBT)

Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the best stocks under $20 to buy for the long term. On August 19, Craig-Hallum analyst Jeff Van Rhee maintained a Buy rating on Cellebrite DI Ltd. (NASDAQ:CLBT).

Bloom Energy (BE) Rides AI Data Center Boom but Faces Cash Burn Risks

A female engineer in a datacenter, wearing a headset, monitoring digital data.

The rating update came after Cellebrite DI Ltd. (NASDAQ:CLBT) reported its fiscal Q2 2025 results on August 14 and announced the appointment of Thomas E. Hogan as CEO.

Cellebrite DI Ltd. (NASDAQ:CLBT) reported an 18% growth in revenue to $113.3 million, with ARR growing 21% to $418.9 million.

Net income for the quarter reached $19.5 million, supporting non-GAAP net income of $30.8 million and adjusted EBITDA of $27.9 million.

Cellebrite DI Ltd. (NASDAQ:CLBT) provides digital investigative solutions for the private and public sectors. The company’s services include value realization, training and advisory, technical customer support, and advanced services.

While we acknowledge the potential of CLBT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CLBT and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.